← All organizations

Moleculin, LLC

For profitWebsite ↗

Also known as: Moleculin Biotech, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Mar 12, 2025

Timeline

2000s

Jun 1, 2006
Moleculin, LLC— Founded

2010s

Oct 29, 2015
AnnaMed— Acquired

Drugs by trial phase (6 distinct, 9 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

AnnaMed

Recent trials (14)

NCT06788756Lead sponsorPhase 2/Phase 3Mar 12, 2025
NCT05879250CollaboratorPhase 2Dec 27, 2024
NCT05319587Study directorPhase 1/Phase 2Sep 29, 2022
NCT05319587Lead sponsorPhase 1/Phase 2Sep 29, 2022
NCT05195723Lead sponsorPhase 1May 11, 2022
NCT04887298Study directorPhase 1/Phase 2Jun 5, 2021
NCT04887298Lead sponsorPhase 1/Phase 2Jun 5, 2021
NCT04702503Lead sponsorPhase 1Mar 8, 2019
NCT04702503Study directorPhase 1Mar 8, 2019
NCT03388749Study directorPhase 1/Phase 2Aug 31, 2018
NCT03388749Lead sponsorPhase 1/Phase 2Aug 31, 2018
NCT03315039Study directorPhase 1/Phase 2Mar 28, 2018
NCT03315039Lead sponsorPhase 1/Phase 2Mar 28, 2018
NCT01826201Lead sponsorPhase 2Mar 1, 2013

Details

Founded: Houston, TX, US Jun 1, 2006
Last known activity: Mar 12, 2025